India’s CRDMO sector growth potential at $22 - $25 Billion by 2035: BCG-IPSO Report
Eleven CRDMOs collaborate to form IPSO with the aim to elevate India’s position in the global pharmaceutical value-chain
Eleven CRDMOs collaborate to form IPSO with the aim to elevate India’s position in the global pharmaceutical value-chain
Fourth-quarter 2024 revenues totaled $17.8 billion, an increase of $3.2 billion
Initiative aimed at enhancing workforce skills and competency in line with industry standards so as to create a talented workforce for the Fourth Industrial Revolution
The MoU signed in 2022 has progressed and culminated in the subsumption of FOGSI-led Manyata initiative’s 20 quality standards across NABH’s Certification programs
Sun Pharma will have the exclusive worldwide rights to commercialise Fibromun
The Academy, led by Professor Ravi P Mahajan CBE, is set to harmonize the efforts of various Apollo entities
Honeywell Quality Management Review helps manufacturers boost efficiency and quality compliance
The fresh funds will be used to enhance customer relationships, expand operations and develop state-of-the-art service
New software solution helps manufacturers digitalize and gain insights from data to increase efficiency
Annapurna will lead the company in India ensuring patient access to its highly innovative medicines and vaccines
Subscribe To Our Newsletter & Stay Updated